Maze Therapeutics reports Q2 2026 results, cites progress on kidney disease pipelineAug 11Quarterly updateMaze Therapeutics
Maze Therapeutics recruiting Phase 2 trial of MZE782 tablets in adult PKU patientsJul 10Trial updateMaze TherapeuticsMZE782
Sign inSign in